Biological qualification of blood units: Considerations about the effects of sample's handling and storage on stability of nucleic acids

Transfusion and Apheresis Science

Volumn 30, Issue 3, 2004, Pages 197-203

  Gessoni, G ^a   Barin, P ^b   Valverde, S ^a   Giacomini, A ^b   Di Natale, C ^b   Orlandini, E ^a   Arreghini, N ^b   De Fusco, G ^b   Frigato, A ^b   Fezzi, M ^b   Antico, F ^a   Marchiori, G ^b  

^a Ospedale Civile   (Italy)

^b Reg Ctr Compensation Co ordination   (Italy)

Author keywords

Biological qualification; Detection limit; HBV DNA; HCV RNA; HIV RNA; Stability; Storage

Indexed keywords

DNA; NUCLEIC ACID; RNA;

CONFERENCE PAPER; FREEZING; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID ANALYSIS; QUANTITATIVE ANALYSIS; VIRUS LOAD;

BLOOD PRESERVATION; DNA, VIRAL; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; NUCLEIC ACIDS; REFRIGERATION; RNA STABILITY; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TEMPERATURE; TIME FACTORS; VIRAL LOAD;

EID: 2542640037     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2003.11.010     Document Type: Conference Paper

References (39)

1. Busch M., Kleinman S. Nucleic acid amplification testing of blood donors for transfusion transmitted infectious disease. Transfusion. 40:2000;143-159
2. Decreto del Ministero Italiano della Salute 29 Marzo 1999
3. Krajden M., Ziermann R., Khan A., Mak A., Leung K., Hendricks D., et al. Qualitative detection of Hepatitis C Virus RNA; Comaparison of analytical sensitivity, clinical performance and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV-RNA transcription-mediated amplification qualitative assay. J. Clin. Microbiol. 40:2002;2903-2907
4. Guidelines for validation of nucleic acid amplification techniques (NAT). European Pharmacopeia, 3rd ed., December 1996
5. Noborg U., Gusdal A., Pisa E., Hedrum A., Lindh M. Automated quantitative analysis of Hepatitis B Virus DNA by using the Cobas Amplicor HBV Monito test. J. Clin. Microbiol. 37:1999;2793-2797
6. Stelzl E., Kormann-Kòement A., Haas J., Daghofer E., Santner B., Marth E., et al. Evaluation of an automated sample preparation protocol for quantitative detection of Hepatitis C Virus RNA. J. Clin. Microbiol. 40:2002;1447-1450
7. Lew J., Reichelderfer P., Fowler M., Bremer J., Carrol R., Cassol S., et al. Determination of levels of human immunodeficiency virus type I RNA in plasma. J. Clin. Microbiol. 36:1998;1471-1479
8. Lopez V., Bourne E., Lutz M., Condreay L. Assessment of the Cobas Amplicor HBV Monitor test for the quantification of serum Hepatitis B Virus DNA levels. J. Clin. Microbiol. 40:2002;1972-1976
9. Alfonso A., Didier J., Plouvier E., Falissard B., Ferey M., Bogard M., et al. Performance of an automated system for quantification of Hepatitis C Virus RNA. J. Virol. Meth. 86:2000;55-60
10. Dickover R., Herman S., Saddio K., Wafer D., Dillon M., Bryson Y. Optimization of specimen handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR. J. Clin. Microbiol. 36:1998;1070-1073
11. Pisani G, Mele C, Bisso G, Wirz M, Gentili G. Nucleic Acid Amplification Technology (NAT) for the detection of Hepatitis C Virus (HCV) in plasma pools. Validation Report. Rapporti ISTISAN 2000/06
12. Guidelines for validation of Nucleic Acid Amplifiaction Technology (NAT) for the detection of Hepatitis C Virus (HCV) RNA in plasma pools. Council of Europe PA/PH/OMCL (98) 22 PROP
13. Marin I., Poljak M., Seme K., Meglic-Volkar J., Maticic M., Lesnicar G., et al. Comparative evaluation of semiautomated COBAS AMPLICOR Hepatitis B Virus(HBV) MONITOR test and manual microwell plate-based AMPLICOR HBV MONITOR test. J. Clin. Microbiol. 39:2001;758-761
14. Chu C., Hussain M., Lok A. Quantitative serum HBV-DNA levels during different stage of chronic Hepatitis B infection. Hepatology. 36:2002;1408-1415
15. Berger A., Branner J., Doerr H., Weber B. Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B Virus and Hepatitis C Virus infection. Intervirology. 41:1998;24-34
16. Manzin A., Solforosi L., Bianchi D., Gabrielli A., Giostra F., Bruno S., et al. Viral load in samples from Hepatitis C Virus (HCV) infected patients with various clinical conditions. Res. Virol. 146:1995;279-284
17. Fang C., Tobler K., Haersche C., Busch M., Phelps B., Leparc G. Fluctuation of HCV viral load before seroconversion in healthy volunteer blood donor. Transfusion. 43:2003;541-544
18. Griffith B., Rigsby M., Garner R., Gordon M., Chako T. Comparison of the Amplicor HIV-1 Monitor test and the nucleic acid sequence based amplification assay for quantitation of Human Immunodeficiency Virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles. J. Clin. Microbiol. 35:1997;3288-3291
19. Grant P., Kitchen A., Barbara J., Hewitt P., Sims C., Garson J., et al. Effects of handling and storage of blood on the stability of Hepatitis C Virus RNA: Implications for NAT test in transfusion medicine. Vox Sanguinis. 78:2000;137-142
20. Sebire K., McGravin K., Land S., Birch C. Stability of human immunodeficiency virus RNA as measured by a commercial PCR based assay. J. Clin. Microbiol. 36:1998;493-498
21. Krajden M., Comandor L., Rifkin O., Grigonew A., Minor J., Kapke G. Assessent of Hepatitis C Virus DNA stability in serum by the Chiron Quantiplex Branched DNA assay. J. Clin. Microbiol. 36:1998;382-386
22. Cardoso M., Koerner K., Hinz W., Lenz C., Schawandt A., Kubanek B. Hepatitis C Virus stability: the issue! Vox Sanguinis. 76:1999;124-127
23. Krajden M., Minor J., Rifkin O., Coamdor L. Effect of multiple freeze-thaw cycles on Hepatitis B Virus DNA and Hepatitis C Virus RNA quantification measured with Branched DNA technology. J. Clin. Microbiol. 37:1999;1683-1686
24. Ginocchio C., Wang X., Kaplan M., Mulligan G., Witt D., Romano J., et al. Effects of specimen collection, processing and storage conditions on stability of Human Immunodeficiency Virus type 1 RNA levels in plasma. J. Clin. Microbiol. 35:1997;2886-2893
25. Kessler H., Stelzl E., Raggam R., Haas J., Kirrchmeir F., Hegenbarth K., et al. Effects of storage ant type of blood collection tibes on Hepatitis C Virus level in whole blood. J. Clin. Microbiol. 35:2001;1788-1790
26. Sun R., Jayakar H., Mendoza Mwisbeski M., Iszczyszyn W., Dragon E. Experience with PCR screening. Dev. Biol. Stand. 102:2000;81-91
27. Sun R., Schilling W., Jayakar H., Ku J., Wang J., Rosenstraus M., et al. Simultaneous extraction of Hepatitis C Virus (HCV), Hpatitis B Virus (HBV) and HIV-1 from plasma and detection of HCV-RNA by a reverse transcriptase polymerase chain reaction assay designed for screening pooled units of donated blood. Transfusion. 39:1999;1111-1119
28. Yang Y., Lamendola M., Mendoza M., Xu D., Nguyen M., Yeh S., et al. Peformance characteristics of the Cobas Ampliscreen HIV-1 test, version 1.5, an assay designed for screening plasma mini-pool. Transfusion. 41:2001;643-651
29. Whalley S., Murray J., Brown D., Webster G., Emary V., Dusheiko G., et al. Kinetics of acute B virus infection in humans. J. Exp. Med. 193:2001;847-854
30. Noborg U., Gusdal A., Horal P., Lindg M. Levels of viraemia in subjects with serological markers of past or chronic Hepatitis B Virus infection. Scand J. Infect. Dis. 32:2000;249-252
31. Baz K., Zheng J., Mazuruk K., Van Le A., Peterson D. Characterization of a novel Hepatitis B Virus mutant: demonstration of mutation-induced Hepatitis B Virus surface antigen group specificity a determinant conformation change and its application in diagnostic assays. Transf. Med. 11:2001;335-362
32. Garcia-Retortillo M., Forns X., Feliu A., Moitinho E., Costa J., Navasa M., et al. Hepatitis C Virus kinetics during and immediately after liver transplantation. Hepatology. 35:2002;680-687
33. Little S., McLean A., Spina A., Richman D., Havlir D. Viral dynamics of acute HIV-1 infection. J. Exp. Med. 6:1999;841-850
34. Garcia F., Vidal C., Gatell J., Miro J., Soriano A., Pumarola T. Viral-load in asyntomatic patients with CD4* lymphocyte counts above 500. × 10(6)L AIDS. 11:1997;53-57
35. Weusten J., van Drimmelen H., Lelie P. Mathematic modelling of the risk of HBV, HCV and HIV transmission by winow phase donation not detected by NAT. Transfusion. 42:2002;537-548
36. Velati C., Romano L., Baruffi L., Pappalettera M., Carreri V., Zanetti A. Residula risk of transfusion transmitted HCV and HIV infections by antibody screening in Italy. Transfusion. 42:2002;966-972
37. Alvarez M., Oyonarte S., Rodriguez P., Hernandez J. Estimated risk of transfusion transmitted viral infections in Spain. Transfusion. 42:2002;994-998
38. Pillonel J., Laperche Pillonel J., Laperche S., Saura C., Desenclos J., Couronce A. Trends in residual risck of transfusion transmitted infections in France between 1992 and 2000. Transfusion. 42:2002;980-988
39. Commission of the European communities. Communication from the commission on the precautionary principle. Brussels 02/02/2002 COM (2000) 1